Persistence of ketosis despite suppression of lipolysis by 16,16-dimethylprostaglandin E2 in experimental diabetic ketoacidosis in rats.
D015064:16,16-Dimethylprostaglandin E2 / Q000494:pharmacology*; D000090:Acetoacetates / Q000097:blood; D000818:Animals; D003921:Diabetes Mellitus, Experimental / Q000378:metabolism*; D016883:Diabetic Ketoacidosis / Q000378:metabolism*; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005990:Glycerol / Q000097:blood; D006885:Hydroxybutyrates / Q000097:blood; D007328:Insulin / Q000494:pharmacology; D007657:Ketone Bodies / Q000097:blood*; D007700:Kinetics; D008053:Lipid Mobilization / Q000187:drug effects*; D008297:Male; D011459:Prostaglandins E, Synthetic / Q000494:pharmacology*; D051381:Rats
D000090:Acetoacetates; D005230:Fatty Acids, Nonesterified; D006885:Hydroxybutyrates; D007328:Insulin; D007657:Ketone Bodies; D011459:Prostaglandins E, Synthetic; D015064:16,16-Dimethylprostaglandin E2; D005990:Glycerol